Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IVAX Insider Trading -- Ignore unavailable to you. Want to Upgrade?

To: flickerful who wrote (428)	1/18/1998 10:24:00 PM
From: 5,17,37,5,101,...	Read Replies (2) \| Respond to of 756

Thanks for the link -- it was all Greek to me except BUY. Orthologic has also invested in Chrysalis which COULD be a lucrative new source of profit in the area of fracture mending. I briefly investigated ZE but noticed only a recent insider decision to sell last summer. We all have certain criteria that must be met before commitment of cash, and one of mine is strong positive insider purchases under several conditions: 1) Broad participation by managment (made initial mistake with Ivx where only Frost had invested; that cost me many thousands). 2) Strong averaging down or up by insiders (now Ivx is a buy) (purchased MTEL at 8, sold 17; purch CLHB 1.6, sold 2.9) 3) Exercise of lots of nonqualified options. (RATL) (purch. OCTL 18, sold 30) Without my initial Ivx error, I would be in Ivx at 7 without any loss. Obviously there are losers even when the criteria are met (bought CTSC at 4 sold 6; bought a little at 5, sold 3 UGH now trading at 2.5), but overall the strategy is a winner. Jackson